First human tests: how a new drug acts in different ethnic groups
NCT ID NCT07133191
Summary
This early research study tested a single dose of an experimental drug called selatogrel in healthy people. The goal was to see how the drug moves through the body and what effects it has, comparing results between 16 Japanese and 16 Caucasian volunteers. This type of study is the first step to see if a drug is safe for future testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel ACT (Anaheim Clinical Trials)
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.